S.64 - Safe and Affordable Drugs from Canada Act of 2017115th Congress (2017-2018)
|Sponsor:||Sen. McCain, John [R-AZ] (Introduced 01/09/2017)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||Senate - 01/09/2017 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.64 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in Senate (01/09/2017)
Safe and Affordable Drugs from Canada Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require the Department of Health and Human Services (HHS) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy that:
- is dispensed by a pharmacist licensed in Canada;
- is purchased for personal use in quantities not greater than a 90-day supply;
- is filled using a valid prescription issued by a physician licensed to practice in the United States; and
- has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved under the FFDCA.
Certain medications may not be imported, including controlled substances and biological products.
The bill establishes a certification process for approving Canadian pharmacies. HHS must publish a list of approved Canadian pharmacies.